Pediatric Drugs

Foreword
pp. 1-2(2)
Author: Fitzgerald, Dominic A.

Clinical Pharmacology Study of Bramitob^®, a Tobramycin Solution for Nebulization, in Comparison with Tobi^®
pp. 3-9(7)
Authors: Poli, Gianluigi; Acerbi, Daniela; Pennini, Roberto; Annamaria Soliani Raschini,; Mario Ermanno Corrado,; Hans Georg Eichler,; Eichler, Irmgard

Efficacy, Safety, and Local Pharmacokinetics of Highly Concentrated Nebulized Tobramycin in Patients with Cystic Fibrosis Colonized with Pseudomonas aeruginosa
pp. 11-20(10)
Authors: Lenoir, Gerard; Yuriy Genadievich Antypkin,; Miano, Angelo; Moretti, Paolo; Zanda, Maurizio; Varoli, Guido; Pier Alessandro Monici Preti,; Nikolay Leonidovich Aryayev,

A Formulation of Aerosolized Tobramycin (Bramitob®) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection: A Double-Blind, Placebo-Controlled, Multicenter Study
pp. 21-31(11)
Authors: Chuchalin, Alexander; Csiszér, Eszter; Gyurkovics, Kàlmàn; Bartnicka, Maria Trawińska; Sands, Dorota; Kapranov, Nikolai; Varoli, Guido; Pier Alessandro Monici Preti,; Mazurek, Henryk